FFAGLDD
FFAGLDD is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release[1].
Product Specifications
CAS Number
[2703745-70-2]
UNSPSC
12352209
Target
MMP
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ffagldd.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=CC=C2)N
Molecular Formula
C37H49N7O12
Molecular Weight
783.82
References & Citations
[1] Zhou Q, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018 May 18;13:2921-2942.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P2004/FFAGLDD-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P2004/
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
MMP-9
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Advanced Glycosylation End Product Specific Receptor (AGER) Antibody
Advanced Glycosylation End Product Specific Receptor (AGER) Antibody
Advanced Glycosylation End Product Specific Receptor (AGER) Antibody
